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doi:10.1016/j.jmu.2012.04.008Objective: The purpose of this study was to evaluate the usefulness of contrast-enhanced
ultrasound for detecting neovascularization in tendinopathic tissues using an animal model.
Methods: Doses of 100 mL and 50 mL collagenase were injected into the left and right Achilles
tendons of six rabbits. Power Doppler ultrasonography was used before and after the adminis-
tration of a contrast agent to evaluate tendon perfusion on Day 0 and Day 14 after the colla-
genase injections. The number of color pixels within the region of interest represented the
amount of vascularity.
Results: The tendon cross-sectional area was similar between Day 0 and Day 14, and compar-
isons between both tendons also appeared to be insignificantly different between these two
times. Noncontrast power Doppler ultrasonography failed to detect more color pixels in the
tendons after collagenase injections in comparison with baseline, whereas a higher peak signal
intensity was identified using contrast enhancement in the collagenase-treated tendons. In
addition, differences in vascularity between the tendons that received different amounts of
collagenase were clearly revealed after the administration of the contrast agents.
Conclusion: The present study demonstrates that contrast-enhanced ultrasound is superior to
the noncontrast ultrasound for measuring hypervascularity in Achilles tendinopathy in a rabbit
model.
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The Achilles tendon, the largest and strongest tendon in the
human body, is derived from the soleus and gastrocnemius
muscles and inserts posteriorly to the calcaneus. Achilles
tendinopathy commonly occurs in competitive and recrea-
tional athletes [1]. Observational data suggest that
competitive athletes have a lifetime incidence of Achilles
tendinopathy of up to 24% [2]. The etiology of Achilles
tendinopathy is multifactorial. Intrinsic factors include
impaired tendon perfusion, older age, female sex, heavy
weight, taller heel height, and ankle instability [3],
whereas extrinsic causes include previous lower limb injury
and vigorous physical activities [4]. The Achilles tendon has
a hypovascular zone of 4e6 cm caudal to its calcaneal
insertion site, where tendon degeneration and tears
commonly occur [5, 6]. In the histology of Achilles tendin-
opathy, interfibrillar glycosaminoglycan proliferation and
collagen fiber disarrangement commonly present, but not
with inflammatory cell infiltration [1]. Some previous
studies have suggested that neovascularization contributes
to painful Achilles tendinopathy. Previous studies have
described sclerosing neovessels in order to relieve pain in
most patients [7]. One study found that higher levels of
glutamate receptors and vascular endothelial growth
factors exist in the vicinity of the nerves in patients with
painful Achilles tendinopathy, suggesting that the increase
in nociceptive nerve fibers and neovascularization occurs in
Achilles tendinopathy [8].
Several imaging tools have been used to evaluate
Achilles tendinopathy, including plain film, computed
tomography (CT), magnetic resonance imaging (MRI), and
ultrasound. Plain film is inexpensive and can be used to
screen for the existence of bony abnormalities. The CT scan
demonstrates a higher sensitivity for detecting calcifica-
tions and is useful for planning surgeries to treat compli-
cated foot and ankle fractures. However, both imaging
modalities fail to delineate tendon morphology and also
result in increased radiation exposure. MRI depicts the
multiplanar anatomy at a high resolution, but it is sensitive
to changes in water content in tendon tissues. Ultrasound,
in comparison with MRI, is less costly, provides an easy
dynamic evaluation, and allows real-time comparisons with
painful sites. Therapeutic injection can also be adminis-
tered under ultrasonographic guidance [5]. Grey-scale
sonography has also been used to reveal that normal
Achilles tendons are composed of parallel arrays of fibrillar
lines in longitudinal planes and appear round-to-ovoid along
transverse planes. Focal hypoechogenic changes, such as
the thickening of the Achilles tendon, are considered
pathological findings. Because neovascularization is often
associated with painful Achilles tendinopathy, we can use
color or power Doppler to detect blood flow in a tendon. A
previous study demonstrated neovascularization in all
symptomatic tendons [9]. Power Doppler is superior to color
Doppler because of its sensitivity to blood flow, and it is
relatively independent of the angle of incidence. Never-
theless, power Doppler is still inadequate for recognizing
the vascularity of hypovascular structures, such as tendons
[7,10]. Because neovascularization is highly correlated
to painful Achilles tendinopathy, this study sought todetermine whether contrast-enhanced ultrasound is more
effective than traditional power Doppler for investigating
hypervascularity in Achilles tendinopathy.
Materials and methods
Animal model
We examined six male New Zealand rabbits (mean weight:
3.2 kg; range: 3.1e3.4 kg) and both Achilles tendons of
each rabbit. All of the rabbits were anesthetized with iso-
flurane, and the hairs of the hind feet were shaved.
According to our pilot study, a subcutaneous injection of
100 mL (10 mg/mL) collagenase (Sigma-Aldrich, St. Louis,
MO, USA) is adequate for inducing swelling and local
erythematous changes over the Achilles tendons, and the
gross appearance typically returns to baseline approxi-
mately 2 weeks later. We injected 100 mL and 50 mL of
collagenase into the left and right leg of each rabbit,
respectively, at 1.5 cm proximal to the bony insertions of
the Achilles tendons. We performed the ultrasonographic
measurement on Day 0 before collagenase injection and on
Day 14 after injection. This project was approved by the
animal ethics committee of National Taiwan University
Hospital.
Ultrasound imaging and protocol
We used an ultrasound machine (Acuson S2000 system,
Siemens, Munich, Germany) equipped with a multifre-
quency transducer (14L5, 6e12 MHz in 2D mode;
5.5e7.5 MHz in Doppler mode) to perform the examina-
tions. Power Doppler was employed to investigate tendon
vascularity and was adjusted to the highest sensitivity that
did not result in artifacts beneath the bony cortex before
administering contrast agents. In order to reduce the
blooming effect, the color gain was reduced to 0 dB while
contrast agents were being introduced. A video retriever
was externally connected to the ultrasound machine for
continuous recording. The ultrasound examinations were
performed on Day 0 before collagenase injection and on
Day 14 after injection. The rabbits were settled in the
prone position with the lower limbs immersed in a water
tank, and the ultrasound probe was fixed along the long axis
of the Achilles tendons (Fig. 1). Grey-color imaging was
used to locate the midpoint of the calcaneus bone in the
transverse plane, and then the probe was turned parallel to
the long axis of the Achilles tendons. The right vertical
border of the scan view was adjusted to pass through the
caudal edge of the calcaneus bone in order to assure that
the same segment was investigated at each time point. We
first captured an image in traditional power Doppler mode
and then performed contrast-enhanced imaging; this was
video recorded for 5 minutes. The total dose of the contrast
agent was approximately 0.32 mL (6.4  108 microbubbles),
and this was injected through each rabbit’s large veins in
the ears, followed by 1.5 mL of a normal saline flush. The
video was analyzed off-line, frame-by-frame, and a freely
downloaded software, KM player (KMPlayer_EN_3.0.0.1442)
was used to retrieve the appropriate images. We selected
Fig. 1 Platform and settings used for sonographic evalua-
tions. The rabbit is settled in the prone position with both hind-
feet immersed in a gasless water tank at a constant tempera-
ture. The ultrasound probe is fixed along the long axis of the
Achilles tendon using a self-made hinge device.
Contrast-enhanced Ultrasound for Tendinopathy 111three mostly enhanced pictures and calculated their aver-
ages of pixels within the region of interest for the outcome
analysis. We measured color pixels within the entire
Achilles tendon to represent the amount of vascularity
using Image J software (National Institutes of Health,Fig. 2 Quantitative analysis of the power Doppler signal intensity.
naked eye, then the KM player was then used to retrieve the approp
brightness of each selected image using Image J software. Then w
Third, we altered the color threshold and changed the color area t
calculate the enhanced areas of the pixels.Bethesda, MD, USA). After adjusting the threshold of the
color histogram, the investigator was able to extract the
area that was enhanced in power Doppler mode [11]. Then,
the “analyze particles” function was used to calculate the
target areas of the pixels (Fig. 2).
Statistics analysis
We used SPSS Statistics software (version 12; SPSS, IBM
Corporation, Somer, NY, USA) to perform the analyses. The
statistical significance was set at a p value <0.05. The
difference between Day 0 and Day 14 after the collagenase
injection was analyzed using the general linear model with
repeated measurements. The Wilcoxon signed-rank test
was used to compare data between the tendons that
received 100 mL and 50 mL collagenase.
Results
The cross-sectional area (CSA), which is correlated with
tendon thickness, was not significantly different between
Day 0 and Day 14 after the collagenase injection into the
bilateral Achilles tendons. Compared with the tendons that
received 50 mL collagenase, those injected with 100 mL
collagenase did not demonstrate an enlarged CSA. Similar
to the CSA comparisons, noncontrast power Doppler ultra-
sonography failed to detect any changes or discrepancies
over time between both sides via measurement of the(A) First, pictures of the enhanced areas were viewed with the
riate images. (B) Second, we adjusted the hue, saturation, and
e extracted the enhanced area from the region of interest. (C)
o red. (D) Finally, we used the “analyze particles” function to
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contrast agents, on Day 14 we identified a peak signal
intensity (PSI) in both tendons that was higher than their
basal values (p Z 0.025 and 0.009 for the left and right
side, respectively). In addition, PSI was not significantly
different between the bilateral tendons on Day 0, whereas
the values on Day 14 appeared more elevated in the
tendons that were administered 100 mL collagenase than
those that were administered 50 mL collagenase (pZ 0.046;
Table 1 and Fig. 3).Discussion
In our study, we found that the CSA 14 days after collage-
nase injection was not significantly different from baseline
in either Achilles tendon. Regarding comparisons between
the bilateral Achilles tendons, the differences in CSA and
vascularity measured using grey-scale or noncontrast power
Doppler ultrasound were insignificant 14 days after colla-
genase injection. However, using contrast-enhanced ultra-
sound (CEUS) allowed us to detect increased vascularity in
the tendons that were treated using a higher dosage of
collagenase in comparison with the contralateral side. A
higher number of neovessels were also detected in both
postinjected tendons in comparison with the basal amounts
that were measured prior to collagenase injection.
Achilles tendinopathy may be initiated by injuries to the
tendons via inflammatory cell infiltration, but Achilles
tendinopathy is actually caused by an increase in matrix
cellular proliferation and extensive neovascularization with
the absence of inflammation [12]. There are two types of
animal tendinopathic models: those that are provoked by
chemical irritants and those provoked by mechanical
overuse. Collagenase, the most common chemical material
used to induce tendinopathy, is a protease that is secreted
by fibroblasts or inflammatory cells and it can degrade the
triple helical structure of collagen, leading to reproducible
and consistent damage to tendons and degeneration fol-
lowed by an inflammatory response [13]. The collagenase
we used in this study was specific to type I collagen. Since
type I collagen composes about 85% of the tendon, we
chose this kind of collagenase. According to previousTable 1 Comparisons between left (post-100 ml injection of
Achilles tendons on Day 0 and Day 14.
Day 0
Tendon cross-sectional area (no. of pixels)
Left Achilles tendon 38,772.5 
Right Achilles tendon 38,927.2 
Color pixels determined using noncontrast power Doppler (no. of
Left Achilles tendon 3258.8 
Right Achilles tendon 2391.0 
Color pixels determined using contrast-enhanced ultrasound (no.
Left Achilles tendon 13,475.0 
Right Achilles tendon 12,271.5 
* Indicates significant difference between the parameters of tendo
# Indicates significant difference between the parameters in the lestudies, the number of neutrophils and macrophages might
increase after collagenase injections, but these numbers
typically return to baseline values within 7e14 days [14].
Therefore, we chose 14 days after the injection of colla-
genase as the time to measure these values. The advantage
of using collagenase to elicit tendinopathy is its similarity
to naturally occurring tendinopathy, which represents
matrix degradation, cellular proliferation, and hyper-
vascularity. Furthermore, the number of neovessels is
proportional to the injected dose, which allows for
comparisons between experimental designs [13].
Contrast-enhanced ultrasound, an emerging imaging
modality that can be used to evaluate angiogenesis, uses
gas-filled and shell-stabilized microbubbles as contrast
agents. The size of the microbubbles ranges between
1e8 mm [15], which can augment backscattered signals
through strong reflections from the gas-fluid interfaces
[10,16,17]. Adverse reactions of using microbubbles as
a contrast agent are rare in humans and are usually tran-
sient without being life threatening, if they occur at all
[18]. In contrast to iodinated CT or gadolinium-based MRI
contrast agents, there have been no reports of nephrotox-
icity using microbubbles [19]. CEUS allows the assessment
of the macro- and microvasculature in various organs,
including the liver, heart, and kidney [17], and has a higher
sensitivity than traditional power Doppler ultrasound for
revealing the microvasculature [20]. CEUS has been used to
detect and characterize focal liver lesions [21], improves
the delineation of the endocardial border and assessment
of myocardial perfusion, and is beneficial for detecting
renal transplant rejection [15]. Nevertheless, based on the
relevant studies that have been published in the literature,
few studies have applied this technique to evaluate ten-
dinopathy [10].
In the present study, noncontrast power Doppler
ultrasound failed to recognize neovascularization in ten-
dinopathic models, whereas CEUS could detect higher
vascularity in Achilles tendons 2 weeks after collagenase
injection. In addition, differences in hypervascularity
following the administration of various amounts of colla-
genase injection could be identified using CEUS. One
explanation is that the newly formed vessels are
extremely small, preventing traditional power Dopplercollagenase) and right (post-50 ml injection of collagenase)
Day 14
3906.6 41,081.7  10,089.4
6497.6 40,573.7  5170.0
pixels)
803.3 2979.2  1477.0
1059.5 3985.6  2152.0
of pixels)
4256.9* 22,667.8  5402.5*,#
1991.1* 18,211.0  3921.0*,#
ns at either side on Day 0 and Day 14.
ft and right Achilles tendons.
Fig. 3 Comparison of the peak signal intensities between noncontrast power Doppler ultrasound and contrast-enhanced ultra-
sound. (A) Noncontrast power Doppler (NPD) failed to show discrepant amounts of blood flow between both legs, whereas (B)
contrast-enhanced ultrasound (CEUS) could identify peak signal intensities in both tendons that was significantly higher than the
basal values on Day 14. The difference in vascularity between the tendons that received different amounts of collagenase
injections were also be clearly revealed. * Indicates significant difference of p < 0.05.
Contrast-enhanced Ultrasound for Tendinopathy 113ultrasound from observing their existence. In contrast,
contrast agents augment the Doppler signals that are
derived from the intravascular microbubbles and facilitate
the depiction of focal perfusion [20]. Another confounding
factor resulted from the accompanying arteries within the
normal Achilles tendons of rabbits. Because we did not
synchronize measurements with their heart beats, the
pulsatile properties of the arteries lead to inaccurate
estimates of the power Doppler signals when using their
color area as a gauge of intensity. Nevertheless, micro-
bubbles could have oversaturated the adjacent midsized
vessels and significantly reduced the influence of arterial
pulsation. Therefore, when using contrast-enhanced
techniques, comparisons of the status before and after
collagenase injection and both sides of the Achilles
tendons mainly depend on the newly developed small
caliber vessels [22].
Two limitations to this study must be acknowledged.
First, we chose 14 days after collagenase injection as the
time to evaluate vascularity; therefore, there might be
greater differences in vascularity or cross-sectional area
during the acute stage. Serial follow-up with shortened
intervals may be helpful. Second, in the present study, we
selected three maximally enhanced pictures using the
naked eye; therefore, vascularity could have been inaccu-
rately estimated because of the pulsatile properties of the
accompanied arteries. Future work may use imaging pro-
cessing software to automatically analyze the enhanced
area and plot the intensity changes according to time.
Further analysis of the time-intensity curves may
contribute information that is more useful to the perfusion
dynamics of tissues with tendinopathy.Conclusions
In the present study, we demonstrated that using CEUS is
more effective than using noncontrast-enhanced power
Doppler ultrasound for detecting hypervascularity in
a rabbit model of Achilles tendinopathy. Our future workwill be dedicated to determining whether this technique
can monitor the therapeutic responses to neo-
vascularization and promoting its application in humans.
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